Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 2026

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 2026Author of the article:WILMINGTON, Del. — Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place October 26-28 in New Orleans, Louisiana, USA.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountAt Booth 1100 in the exhibit hall, Roquette’s Health & Pharma Solutions team will share their expertise across controlled-release technologies, hydroxypropyl beta-cyclodextrins, and sustainable formulation approaches, alongside a comprehensive portfolio of innovative solutions designed to address the evolving needs of pharmaceutical developers.This advertisement has not loaded yet, but your article continues below.“AAPS PharmSci 360 is a key opportunity to share our latest innovations, as well as highlight the breadth and depth of our scientific know-how that helps our customers solve complex formulation challenges,” said Peter Freed, Head of Technical Service & Development North America for Roquette’s Health & Pharma Solutions Business Unit. “From advanced drug delivery platforms to sustainability-focused excipient solutions, our team is committed to helping our customers accelerate development, enhance product performance, and bring meaningful therapies to patients.”Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againExploring the Science Behind Roquette’s Advanced SolutionsRoquette scientists will present research and technical insights across a range of formulation and drug delivery challenges at AAPS PharmSci 360. Highlights include:To Syringe or Not to Syringe: An Excipient-based Strategy to Reduce Viscosity and Improve Subcutaneous Injectability, lead author Jiayi Huang, Ph.D., Senior Biopharma Scientist, presented by Wen Chin Foo, Ph.D., Senior Biopharma ScientistEffect of Sodium Alginate Material Attributes on Melatonin Controlled Release Tablet Performance presented by lead author Yeli Zhang, Ph.D., Senior Lead Applications ScientistRole of Polyethylene Oxide Molecular Weight and Concentration in Modulating Drug Release from Hydrophilic Matrix Tablets presented by lead author Nasrin Mahmoudi, Ph.D., Senior Lead Applications ScientistMicrobiota-triggered Excipient Unlocks Colon Delivery of Oral mAbs presented by Wen Chin Foo, Ph.D., Senior Biopharma ScientistTechnical presentations at the 360 stages in the exhibit hallFrom Molecule to Formulation – How Excipient Properties Impact Product Performance presented by True Rogers, Ph.D., Technical Fellow, and Peter Freed, Ph.D., Head of Technical Service and Development North America.Overcoming the Viscosity Barrier: Hydroxypropyl Beta-Cyclodextrin (HPβCD) Enables Ultrafiltration/Diafiltration of High-concentration Protein presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist.Enabling Robust GLP-1 Peptide Formulations: Hydroxypropyl-β-Cyclodextrin Enhances Solubility and Stress Stability​ presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist.Learn more about Roquette’s posters, presentations, and booth activities here.This advertisement has not loaded yet, but your article continues below.Roquette is a global leader in sustainable plant-based solutions, driving innovation and strong partnerships that are shaping the future of nutrition, health, and bioindustry.The company harnesses natural resources such as wheat, corn, seaweed, and cellulose to craft high-performance ingredients used in everyday foods, oral medications, advanced biopharmaceuticals, and a range of bio-based products.A family-owned company with over 90 years of expertise and 11,000 employees, Roquette serves clients in over 150 countries and is committed to creating lasting value for customers, patients, consumers, and society.Together, we turn the potential of nature into the essentials of life.Discover more about Roquette here.View source version on businesswire.com: Global Head of CommunicationsRoquette’s Health & Pharma Solutions Business UnitThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.